BioCentury | Jul 13, 2009
Company News

Cellumen sales and marketing update

...oxidative stress, mitochondrial function, apoptosis, DNA damage, fatty acid accumulation, cellular hypertrophy and cellular viability. Cellumen Inc....
BioCentury | Feb 16, 2009
Company News

Cellumen management update

Cellumen Inc. , Pittsburgh, Pa. Business: ADMET, Supply/Service Promoted: Patricia Johnston to CSO from VP of discovery programs WIR Staff...
BioCentury | Dec 22, 2008
Company News

Cellumen sales and marketing update

...Systems Biology panel to predict cardiac hypertrophy as part of its CellCiphr toxicology profiling service. Cellumen Inc....
BioCentury | Oct 6, 2008
Company News

Cellumen, Alzheimer's Drug Discovery Foundation deal

...Cellumen received undisclosed funding from the foundation to create a cellular model of Alzheimer's disease. Cellumen...
...Cellumen will retain rights to any IP discovered, and the foundation is eligible for royalties. Cellumen Inc....
BioCentury | Aug 25, 2008
Company News

Cellumen, Mitsubishi Tanabe Pharma deal

...develop toxicity biomarker panels for use with the pharma’s preclinical compounds. Terms were not disclosed. Cellumen Inc....
BioCentury | Jul 21, 2008
Company News

Cellumen diagnostic, pharmacogenetics news

...Cernostics Pathology Inc. The spinout will provide digital imaging pathology and diagnostics for personalized medicine. Cellumen...
...of Cernostics. Michel Nederlof, formerly president of QED Imaging Inc., will be president and CTO. Cellumen...
...a breast cancer test in validation testing that is being co-developed with the Mayo Clinic. Cellumen Inc....
BioCentury | Dec 10, 2007
Finance

Ebb & Flow

...Cohon are the outgoing co-chairs. Taylor is the president and CEO of systems biology company Cellumen...
BioCentury | Oct 8, 2007
Company News

Cellumen, Mayo Foundation for Medical Education and Research deal

...patient profile test to improve diagnosis and treatment for individualized medicine. The collaboration will use Cellumen's...
...to patient sampling. The resulting assay will be jointly owned. Further terms were not disclosed. Cellumen Inc....
BioCentury | Nov 13, 2006
Company News

Cellumen scientific advisory board update

Cellumen Inc. , Pittsburgh, Penn. Business: Proteomics Appointed: Leroy Hood, president of the Institute for Systems Biology WIR Staff...
BioCentury | Aug 28, 2006
Company News

Cellumen board of directors update

Cellumen Inc. , Pittsburgh, Penn. Business: Proteomics Appointed: Rosemary Mazanet, CEO of Breakthrough Therapeutics LLC and acting CEO of Access Pharmaceuticals Inc. WIR Staff...
Items per page:
1 - 10 of 14
BioCentury | Jul 13, 2009
Company News

Cellumen sales and marketing update

...oxidative stress, mitochondrial function, apoptosis, DNA damage, fatty acid accumulation, cellular hypertrophy and cellular viability. Cellumen Inc....
BioCentury | Feb 16, 2009
Company News

Cellumen management update

Cellumen Inc. , Pittsburgh, Pa. Business: ADMET, Supply/Service Promoted: Patricia Johnston to CSO from VP of discovery programs WIR Staff...
BioCentury | Dec 22, 2008
Company News

Cellumen sales and marketing update

...Systems Biology panel to predict cardiac hypertrophy as part of its CellCiphr toxicology profiling service. Cellumen Inc....
BioCentury | Oct 6, 2008
Company News

Cellumen, Alzheimer's Drug Discovery Foundation deal

...Cellumen received undisclosed funding from the foundation to create a cellular model of Alzheimer's disease. Cellumen...
...Cellumen will retain rights to any IP discovered, and the foundation is eligible for royalties. Cellumen Inc....
BioCentury | Aug 25, 2008
Company News

Cellumen, Mitsubishi Tanabe Pharma deal

...develop toxicity biomarker panels for use with the pharma’s preclinical compounds. Terms were not disclosed. Cellumen Inc....
BioCentury | Jul 21, 2008
Company News

Cellumen diagnostic, pharmacogenetics news

...Cernostics Pathology Inc. The spinout will provide digital imaging pathology and diagnostics for personalized medicine. Cellumen...
...of Cernostics. Michel Nederlof, formerly president of QED Imaging Inc., will be president and CTO. Cellumen...
...a breast cancer test in validation testing that is being co-developed with the Mayo Clinic. Cellumen Inc....
BioCentury | Dec 10, 2007
Finance

Ebb & Flow

...Cohon are the outgoing co-chairs. Taylor is the president and CEO of systems biology company Cellumen...
BioCentury | Oct 8, 2007
Company News

Cellumen, Mayo Foundation for Medical Education and Research deal

...patient profile test to improve diagnosis and treatment for individualized medicine. The collaboration will use Cellumen's...
...to patient sampling. The resulting assay will be jointly owned. Further terms were not disclosed. Cellumen Inc....
BioCentury | Nov 13, 2006
Company News

Cellumen scientific advisory board update

Cellumen Inc. , Pittsburgh, Penn. Business: Proteomics Appointed: Leroy Hood, president of the Institute for Systems Biology WIR Staff...
BioCentury | Aug 28, 2006
Company News

Cellumen board of directors update

Cellumen Inc. , Pittsburgh, Penn. Business: Proteomics Appointed: Rosemary Mazanet, CEO of Breakthrough Therapeutics LLC and acting CEO of Access Pharmaceuticals Inc. WIR Staff...
Items per page:
1 - 10 of 14